Literature DB >> 28944771

The spectrum of T cell metabolism in health and disease.

Glenn R Bantug1, Lorenzo Galluzzi2,3,4, Guido Kroemer4,5,6,7,8,9,10, Christoph Hess1.   

Abstract

In healthy individuals, metabolically quiescent T cells survey lymph nodes and peripheral tissues in search of cognate antigens. During infection, T cells that encounter cognate antigens are activated and - in a context-specific manner - proliferate and/or differentiate to become effector T cells. This process is accompanied by important changes in cellular metabolism (known as metabolic reprogramming). The magnitude and spectrum of metabolic reprogramming as it occurs in T cells in the context of acute infection ensure host survival. By contrast, altered T cell metabolism, and hence function, is also observed in various disease states, in which T cells actively contribute to pathology. In this Review, we introduce the idea that the spectrum of immune cell metabolic states can provide a basis for categorizing human diseases. Specifically, we first summarize the metabolic and interlinked signalling requirements of T cells responding to acute infection. We then discuss how metabolic reprogramming of T cells is linked to disease.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28944771     DOI: 10.1038/nri.2017.99

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  237 in total

Review 1.  Metabolic control of epigenetics in cancer.

Authors:  Adam Kinnaird; Steven Zhao; Kathryn E Wellen; Evangelos D Michelakis
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

Review 2.  The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases.

Authors:  Je-Min Choi; Alfred L M Bothwell
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

3.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 4.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

Review 5.  Tumor metabolism as modulator of immune response and tumor progression.

Authors:  Eva Gottfried; Marina Kreutz; Andreas Mackensen
Journal:  Semin Cancer Biol       Date:  2012-03-03       Impact factor: 15.707

6.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Koji Eto; Hiroshi Yamashita; Mitsuru Ohsugi; Makoto Otsu; Kazuo Hara; Kohjiro Ueki; Seiryo Sugiura; Kotaro Yoshimura; Takashi Kadowaki; Ryozo Nagai
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

Review 7.  Diversity in T cell memory: an embarrassment of riches.

Authors:  Stephen C Jameson; David Masopust
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

8.  Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis.

Authors:  Zhen Yang; Yi Shen; Hisashi Oishi; Eric L Matteson; Lu Tian; Jörg J Goronzy; Cornelia M Weyand
Journal:  Sci Transl Med       Date:  2016-03-23       Impact factor: 17.956

9.  Efficient cross-presentation depends on autophagy in tumor cells.

Authors:  Yuhuan Li; Li-Xin Wang; Guojun Yang; Fang Hao; Walter J Urba; Hong-Ming Hu
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

10.  IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3.

Authors:  Reiner K W Mailer; Anne-Laure Joly; Sang Liu; Szabolcs Elias; Jesper Tegner; John Andersson
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

View more
  122 in total

Review 1.  Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting.

Authors:  Vijay Kumar
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

2.  Metabolic enzymes expressed by cancer cells impact the immune infiltrate.

Authors:  Gautier Stoll; Margerie Kremer; Normal Bloy; Adrien Joseph; Maria Castedo; Guillaume Meurice; Christophe Klein; Lorenzo Galluzzi; Judith Michels; Guido Kroemer
Journal:  Oncoimmunology       Date:  2019-03-30       Impact factor: 8.110

Review 3.  Helper T cell differentiation.

Authors:  Jordy Saravia; Nicole M Chapman; Hongbo Chi
Journal:  Cell Mol Immunol       Date:  2019-03-12       Impact factor: 11.530

4.  Translating immunometabolism: towards curing human diseases by targeting metabolic processes underpinning the immune response.

Authors:  S Dimeloe; C Mauro
Journal:  Clin Exp Immunol       Date:  2019-08       Impact factor: 4.330

Review 5.  Trial Watch: Toll-like receptor agonists in cancer immunotherapy.

Authors:  Melody Smith; Elena García-Martínez; Michael R Pitter; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-10-11       Impact factor: 8.110

6.  T cell activation triggers reversible inosine-5'-monophosphate dehydrogenase assembly.

Authors:  Krisna C Duong-Ly; Yin-Ming Kuo; Matthew C Johnson; Joy M Cote; Justin M Kollman; Jonathan Soboloff; Glenn F Rall; Andrew J Andrews; Jeffrey R Peterson
Journal:  J Cell Sci       Date:  2018-09-05       Impact factor: 5.285

Review 7.  Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease.

Authors:  Marc Y Donath; Daniel T Meier; Marianne Böni-Schnetzler
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

8.  Polarized mitochondria as guardians of NK cell fitness.

Authors:  Laura Surace; Jean-Marc Doisne; Pedro Escoll; Solenne Marie; Valerie Dardalhon; Carys Croft; Anna Thaller; Davide Topazio; Angelo Sparaneo; Antonia Cama; Olimpia Musumeci; Aurelio d'Ecclesia; Carmen Buchrieser; Naomi Taylor; James P Di Santo
Journal:  Blood Adv       Date:  2021-01-12

Review 9.  Impact of oncogenic pathways on evasion of antitumour immune responses.

Authors:  Stefani Spranger; Thomas F Gajewski
Journal:  Nat Rev Cancer       Date:  2018-01-12       Impact factor: 60.716

10.  E3 Ubiquitin Ligase Von Hippel-Lindau Protein Promotes Th17 Differentiation.

Authors:  Alisha Chitrakar; Scott A Budda; Jacob G Henderson; Robert C Axtell; Lauren A Zenewicz
Journal:  J Immunol       Date:  2020-07-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.